Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Cash from Investing Activities (2019 - 2025)

Historic Cash from Investing Activities for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to -$4.8 million.

  • Harmony Biosciences Holdings' Cash from Investing Activities fell 74281.88% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$29.2 million, marking a year-over-year increase of 6969.45%. This contributed to the annual value of -$67.5 million for FY2024, which is 4531.75% down from last year.
  • Per Harmony Biosciences Holdings' latest filing, its Cash from Investing Activities stood at -$4.8 million for Q3 2025, which was down 74281.88% from -$19.6 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Cash from Investing Activities' 5-year high stood at $2.4 million during Q1 2025, with a 5-year trough of -$100.0 million in Q1 2021.
  • For the 5-year period, Harmony Biosciences Holdings' Cash from Investing Activities averaged around -$21.0 million, with its median value being -$7.5 million (2023).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 3478709.68% in 2022, then surged by 19163.59% in 2024.
  • Over the past 5 years, Harmony Biosciences Holdings' Cash from Investing Activities (Quarter) stood at -$93000.0 in 2021, then plummeted by 50324.73% to -$46.9 million in 2022, then rose by 23.09% to -$36.1 million in 2023, then soared by 80.07% to -$7.2 million in 2024, then surged by 33.37% to -$4.8 million in 2025.
  • Its last three reported values are -$4.8 million in Q3 2025, -$19.6 million for Q2 2025, and $2.4 million during Q1 2025.